Phase I and pharmacokinetic (PK) study of oblimersen, a proapoptotic Bcl-2 targeting oligonucleotide, in combination with doxorubicin and docetaxel in metastatic and locally advanced breast cancer (BC)

Locally Advanced ◽

In regard to Kao et al.: Concomitant radiation therapy and paclitaxel for unresectable locally advanced breast cancer: Results from two consecutive Phase I/II trials (Int J Radiat Oncol Biol Phys 2005;61:1045–1053)

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2005.06.045 ◽

2005 ◽

Vol 63 (4) ◽

pp. 1276 ◽

Cited By ~ 2

Author(s):

Silvia C. Formenti

Keyword(s):

Breast Cancer ◽

Radiation Therapy ◽

Phase I ◽

Advanced Breast Cancer ◽

Radiat Oncol Biol Phys ◽

Locally Advanced ◽

Advanced Breast ◽

Consecutive Phase

Phase I and pharmacokinetic (PK) study of oblimersen, a proapoptotic Bcl-2 targeting oligonucleotide, in combination with doxorubicin and docetaxel in metastatic and locally advanced breast cancer (BC)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.3117 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 3117-3117

Author(s):

F. J. Esteva ◽

T. L. Madden ◽

J. Lammey ◽

W. F. Symmans ◽

D. J. Booser ◽

...

Keyword(s):

Breast Cancer ◽

Phase I ◽

Advanced Breast Cancer ◽

Locally Advanced ◽

A phase I-II study of the histone deacetylase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer

Breast Cancer Research and Treatment ◽

10.1007/s10549-014-3008-5 ◽

2014 ◽

Vol 146 (1) ◽

pp. 145-152 ◽

Cited By ~ 25

Author(s):

Yifan Tu ◽

Dawn L. Hershman ◽

Kapil Bhalla ◽

Warren Fiskus ◽

Christine M. Pellegrino ◽

...

Keyword(s):

Breast Cancer ◽

Phase I ◽

Advanced Breast Cancer ◽

Histone Deacetylase ◽

Histone Deacetylase Inhibitor ◽

Locally Advanced ◽

Advanced Breast ◽

Weekly Paclitaxel ◽

Deacetylase Inhibitor

Erratum to: Investigation of ototoxicity of artesunate as add-on therapy in patients with metastatic or locally advanced breast cancer: new audiological results from a prospective, open, uncontrolled, monocentric phase I study

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-016-3023-9 ◽

2016 ◽

Vol 77 (6) ◽

pp. 1321-1321 ◽

Cited By ~ 2

Author(s):

Miriam König ◽

Cornelia von Hagens ◽

Sebastian Hoth ◽

Ingo Baumann ◽

Ingeborg Walter-Sack ◽

...

Keyword(s):

Breast Cancer ◽

Phase I ◽

Advanced Breast Cancer ◽

Phase I Study ◽

Locally Advanced ◽

Phase I-II study of the histone deacetytase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.598 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 598-598

Author(s):

Yifan Tu ◽

Dawn L. Hershman ◽

Christine M. Pellegrino ◽

Eleni Andreopoulou ◽

Della Makower ◽

...

Keyword(s):

Breast Cancer ◽

Phase I ◽

Advanced Breast Cancer ◽

Locally Advanced ◽

Advanced Breast ◽

Weekly Paclitaxel

A phase I/II study of neoadjuvant liposomal doxorubicin, paclitaxel, and hyperthermia in locally advanced breast cancer

International Journal of Hyperthermia ◽

10.3109/02656731003639364 ◽

2010 ◽

Vol 26 (5) ◽

pp. 514-521 ◽

Cited By ~ 45

Author(s):

Zeljko Vujaskovic ◽

Dong W. Kim ◽

Ellen Jones ◽

Lan Lan ◽

Linda Mccall ◽

...

Keyword(s):

Breast Cancer ◽

Phase I ◽

Advanced Breast Cancer ◽

Liposomal Doxorubicin ◽

Locally Advanced ◽

Investigation of ototoxicity of artesunate as add-on therapy in patients with metastatic or locally advanced breast cancer: new audiological results from a prospective, open, uncontrolled, monocentric phase I study

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-016-2960-7 ◽

2016 ◽

Vol 77 (2) ◽

pp. 413-427 ◽

Cited By ~ 26

Author(s):

Miriam König ◽

Cornelia von Hagens ◽

Sebastian Hoth ◽

Ingo Baumann ◽

Ingeborg Walter-Sack ◽

...

Keyword(s):

Breast Cancer ◽

Phase I ◽

Advanced Breast Cancer ◽

Phase I Study ◽

Locally Advanced ◽

A Phase I/II Study of Neoadjuvant Liposomal Doxorubicin, Paclitaxel and Hyperthermia in Locally Advanced Breast Cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2008.06.751 ◽

2008 ◽

Vol 72 (1) ◽

pp. S183-S184

Author(s):

D.W. Kim ◽

K. Blackwell ◽

Z. Vujaskovic ◽

O. Craciunescu ◽

P. Stauffer ◽

...

Keyword(s):

Breast Cancer ◽

Phase I ◽

Advanced Breast Cancer ◽

Liposomal Doxorubicin ◽

Locally Advanced ◽

Faculty Opinions recommendation of Targeted inhibition of farnesyltransferase in locally advanced breast cancer: a phase I and II trial of tipifarnib plus dose-dense doxorubicin and cyclophosphamide.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.14782.472311 ◽

2006 ◽

Author(s):

Debu Tripathy

Keyword(s):

Breast Cancer ◽

Phase I ◽

Advanced Breast Cancer ◽

Locally Advanced ◽

Advanced Breast ◽

Targeted Inhibition ◽

Dose Dense ◽

Phase I And Ii

Concomitant radiation therapy and paclitaxel for unresectable locally advanced breast cancer: Results from two consecutive Phase I/II trials

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2004.07.714 ◽

2005 ◽

Vol 61 (4) ◽

pp. 1045-1053 ◽

Cited By ~ 36

Author(s):

Johnny Kao ◽

Suzanne D. Conzen ◽

Nora T. Jaskowiak ◽

David H. Song ◽

Wendy Recant ◽

...

Keyword(s):

Breast Cancer ◽

Radiation Therapy ◽

Phase I ◽

Advanced Breast Cancer ◽

Locally Advanced ◽

Advanced Breast ◽

Consecutive Phase